Medical Health Cluster


New Data Confirm Risk of Guillain-Barre With J&J COVID Shot

New surveillance data from the Vaccine Safety Datalink confirm a small but statistically significant increased risk for Guillain-Barré syndrome (GBS) in the 3 weeks after receipt of the Janssen/Johnson & Johnson COVID-19 vaccine. The Janssen vaccine (Ad26.COV2.S) is a replication-incompetent adenoviral vector vaccine. The data show no increased risk of […]

Read More

Sudáfrica comunica una efectividad de la doble dosis de la vacuna J&J del 85% frente a hospitalización por ómicron

Según Medscape Infectious Diseases, el responsable de la South Africa´s Medical Research Council ha comunicado que la doble dosis de la vacuna Ad26.CoV2-S de Janssen (J&J) tiene una efectividad del 85% para las hospitalizaciones causadas por la variante ómicron y que se mantiene al menos durante dos meses. El estudio incluyó 477.234 […]

Read More

CDC Study Says Moderna Vaccine More Effective Than Pfizer and J&J

A nationwide study of more than 3,600 adults found the Moderna vaccine does a better job at preventing COVID-19 hospitalizations than the two other vaccines being used in the United States, the Centers for Disease Control and Protection said Friday. “Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 […]

Read More

COVID-19 Vaccines: Safety in Pregnancy / J&J Data / Breakthrough Infections / Skilled Nursing Facilities

Here are some of the latest developments on the COVID-19 vaccines: Safety of vaccine in pregnancy: Early results indicate that COVID-19 vaccination appears to be safe in the third trimester of pregnancy, according to a CDC study in the New England Journal of Medicine. Researchers compiled data from the v-safe pregnancy registry and […]

Read More